Literature DB >> 12970145

Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy.

C Skipper1, J M Guy, J Parkes, P Roderick, W M Rosenberg.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection is a major public health problem recognised by the UK National Strategy that proposes that a care pathway for assessment, diagnosis, and treatment be established in all prisons, integrated within managed clinical networks. A prison sentence provides the opportunity to focus on traditionally hard to reach patients. AIMS: To evaluate the prevalence of HCV infection in a UK prison cluster and to assess the effectiveness of a prison outreach service for hepatitis C.
SUBJECTS: Male prisoners.
METHODS: A nurse specialist led clinic within a cluster of adult prisons was established, offering health education on hepatitis C, advice on harm minimisation, and HCV testing. Infected prisoners were offered access to a care pathway leading to treatment. Outcome measures were uptake of the service, and diagnosis and treatment of hepatitis C.
RESULTS: A total of 8.5% of 1618 prisoners accepted testing: 30% had active infection with HCV. Most were ineligible for treatment due to psychiatric illness or did not receive treatment for logistic reasons. Injecting drug use was the major risk factor in all cases. Only 7% of HCV polymerase chain amplification positive inmates received treatment in prison.
CONCLUSION: There is a large pool of HCV infected prisoners at risk of complications, constituting a source of infection during their sentence and after discharge. A prison outreach clinic and care pathway was perceived as effective in delivering health education, reducing the burden on prison and hospital services. It provided an opportunity for intervention but had a limited effect in eradicating HCV in prisoners and it remains unclear how this might be achieved.

Entities:  

Mesh:

Year:  2003        PMID: 12970145      PMCID: PMC1773842          DOI: 10.1136/gut.52.10.1500

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.

Authors:  A R Weild; O N Gill; D Bennett; S J Livingstone; J V Parry; L Curran
Journal:  Commun Dis Public Health       Date:  2000-06

2.  Clinical guidelines on the management of hepatitis C.

Authors:  J C Booth; J O'Grady; J Neuberger
Journal:  Gut       Date:  2001-07       Impact factor: 23.059

Review 3.  Health care needs assessment in prisons: a toolkit.

Authors:  T Marshall; S Simpson; A Stevens
Journal:  J Public Health Med       Date:  2001-09

4.  Unexplained hepatitis C virus antibody seroconversion in established blood donors.

Authors:  H I Atrah; F A Ala; M M Ahmed; F Hutchinson; D Gough; K Baker
Journal:  Transfusion       Date:  1996-04       Impact factor: 3.157

5.  Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing.

Authors:  C Ward; G Tudor-Williams; T Cotzias; S Hargreaves; L Regan; G R Foster
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

6.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.

Authors:  S Allwright; F Bradley; J Long; J Barry; L Thornton; J V Parry
Journal:  BMJ       Date:  2000-07-08

7.  Comparison between self-reported hepatitis B, hepatitis C, and HIV antibody status and oral fluid assay results in Irish prisoners.

Authors:  L Thornton; J Barry; J Long; S Allwright; F Bradley; J V Parry
Journal:  Commun Dis Public Health       Date:  2000-12

8.  Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.

Authors:  D Goldberg; S Cameron; J McMenamin
Journal:  Commun Dis Public Health       Date:  1998-06

9.  Blood-borne virus infections among Australian injecting drug users: implications for spread of HIV.

Authors:  N Crofts; J L Hopper; R Milner; A M Breschkin; D S Bowden; S A Locarnini
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

10.  Hepatitis C virus infection in the asymptomatic British blood donor.

Authors:  D J Mutimer; R F Harrison; K B O'Donnell; J Shaw; B A Martin; H Atrah; F A Ala; S Skidmore; S G Hubscher; J M Neuberger
Journal:  J Viral Hepat       Date:  1995       Impact factor: 3.728

  10 in total
  22 in total

1.  Access to treatment of hepatitis C in prison inmates.

Authors:  Paul Strock; Joël Mossong; Karine Hawotte; Vic Arendt
Journal:  Dig Dis Sci       Date:  2008-08-29       Impact factor: 3.199

2.  Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran.

Authors:  Amir Houshang Mohammad Alizadeh; Seyed Moayed Alavian; Khalil Jafari; Nastaran Yazdi
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

3.  An overview of the prison population and the general health status of prisoners.

Authors:  E Heidari; C Dickinson; C Dickson; T Newton
Journal:  Br Dent J       Date:  2014-07-11       Impact factor: 1.626

4.  Preventive care for women in prison: a qualitative community health assessment of the Papanicolaou test and follow-up treatment at a California state women's prison.

Authors:  Catherine G Magee; Jen R Hult; Ruby Turalba; Shelby McMillan
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

Review 5.  Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.

Authors:  Iain F Brew; Christine Butt; Nat Wright
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

6.  Improving access to treatment for patients with chronic hepatitis C through outreach.

Authors:  Ahmed Mohamed Elsharkawy; Carolyn Miller; Andrea Hearn; Gertrud Buerstedde; Ashley Price; Stuart McPherson
Journal:  Frontline Gastroenterol       Date:  2012-12-14

Review 7.  Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.

Authors:  Emma Day; Margaret Hellard; Carla Treloar; Julie Bruneau; Natasha K Martin; Anne Øvrehus; Olav Dalgard; Andrew Lloyd; John Dillon; Matt Hickman; Jude Byrne; Alain Litwin; Mojca Maticic; Philip Bruggmann; Havard Midgard; Brianna Norton; Stacey Trooskin; Jeffrey V Lazarus; Jason Grebely
Journal:  Liver Int       Date:  2018-09-22       Impact factor: 5.828

Review 8.  Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment.

Authors:  Rosa Zampino; Nicola Coppola; Caterina Sagnelli; Giovanni Di Caprio; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-09-28

Review 9.  Controversies in and challenges to our understanding of hepatitis C.

Authors:  Robert G Batey
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

10.  Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons.

Authors:  Natasha K Martin; Matthew Hickman; Alec Miners; Sharon J Hutchinson; Avril Taylor; Peter Vickerman
Journal:  BMJ Open       Date:  2013-08-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.